SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-011064
Filing Date
2024-04-17
Accepted
2024-04-17 20:21:17
Documents
1
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 form4-04182024_120410.html 4  
1 form4-04182024_120410.xml 4 6516
  Complete submission text file 0001415889-24-011064.txt   8260
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1517 CHAMPLAIN CREST WAY CARY NC 27513
Business Address 1517 CHAMPLAIN CREST WAY CARY NC 27513 781-308-0823
Syntone Ventures LLC (Reporting) CIK: 0001814394 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 24852555